Investors & Media
Press Releases
2021
-
- March 23, 2021
-
Anokion Initiates Patient Dosing in Phase 1 Trial of ANK-700 for the Treatment of Multiple Sclerosis
Read More
-
- March 16, 2021
-
Anokion Announces Initiation of Multiple-Ascending Dose Portion of its Phase 1 Clinical Trial with KAN-101 for the Treatment of Celiac Disease
Read More
-
- March 04, 2021
-
Kristin Neff speaks at the Celiac Disease Foundation 2021 Virtual Patient Education and Advocacy Summit
Read More
-
- March 03, 2021
-
Anokion to Present at the 2021 Celiac Disease Foundation Virtual Patient Education & Advocacy Summit
Read More
-
- March 01, 2021
-
Anokion Announces Publication in Science Immunology
Read More
-
- February 23, 2021
-
Anokion Appoints Deborah Geraghty, Ph.D., as President and Chief Executive Officer
Read More